Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Liemberger

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Matrix Biology Plus|February 5, 2021
Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studiesOlivier Bornert, Thomas Kocher, Christine Gretzmeier, et al.
International Journal of Molecular Sciences|March 10, 2018
RNA Trans-Splicing Modulation via Antisense Molecule InterferenceBernadette Liemberger, Josefina Piñón Hofbauer, Verena Wally, et al.
The Journal of Investigative Dermatology|March 7, 2020
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis BullosaThomas Kocher, Oliver Patrick March, Johannes Bischof, et al.
International Journal of Molecular Sciences|March 29, 2023
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis BullosaJanine Zwicklhuber, Thomas Kocher, Bernadette Liemberger, et al.
International Journal of Molecular Sciences|January 23, 2024
Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Lisa Trattner, Bernadette Liemberger, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
A non-viral and selection-free <i>COL7A1</i> HDR approach with improved safety profile for dystrophic epidermolysis bullosaThomas Kocher, Johannes Bischof, Simone Alexandra Haas, et al.
International Journal of Molecular Sciences|March 11, 2023
<i>COL7A1</i> Editing via RNA <i>Trans</i>-Splicing in RDEB-Derived Skin EquivalentsBernadette Liemberger, Johannes Bischof, Michael Ablinger, et al.
Frontiers in Medicine|September 12, 2022
<i>COL17A1</i> editing <i>via</i> homology-directed repair in junctional epidermolysis bullosaIgor Petković, Johannes Bischof, Thomas Kocher, et al.
International Journal of Molecular Sciences|April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis BullosaMichael Ablinger, Thomas Lettner, Nicole Friedl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosaJohannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Matrix Biology Plus|February 5, 2021
Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studiesOlivier Bornert, Thomas Kocher, Christine Gretzmeier, et al.
International Journal of Molecular Sciences|March 10, 2018
RNA Trans-Splicing Modulation via Antisense Molecule InterferenceBernadette Liemberger, Josefina Piñón Hofbauer, Verena Wally, et al.
The Journal of Investigative Dermatology|March 7, 2020
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis BullosaThomas Kocher, Oliver Patrick March, Johannes Bischof, et al.
International Journal of Molecular Sciences|March 29, 2023
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis BullosaJanine Zwicklhuber, Thomas Kocher, Bernadette Liemberger, et al.
International Journal of Molecular Sciences|January 23, 2024
Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Lisa Trattner, Bernadette Liemberger, et al.
Molecular Therapy. Nucleic Acids|August 30, 2021
A non-viral and selection-free <i>COL7A1</i> HDR approach with improved safety profile for dystrophic epidermolysis bullosaThomas Kocher, Johannes Bischof, Simone Alexandra Haas, et al.
International Journal of Molecular Sciences|March 11, 2023
<i>COL7A1</i> Editing via RNA <i>Trans</i>-Splicing in RDEB-Derived Skin EquivalentsBernadette Liemberger, Johannes Bischof, Michael Ablinger, et al.
Frontiers in Medicine|September 12, 2022
<i>COL17A1</i> editing <i>via</i> homology-directed repair in junctional epidermolysis bullosaIgor Petković, Johannes Bischof, Thomas Kocher, et al.
International Journal of Molecular Sciences|April 3, 2021
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis BullosaMichael Ablinger, Thomas Lettner, Nicole Friedl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosaJohannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Pageof 2